Linked Data API

Show Search Form

Search Results

732999
unstar this property registered interest false more like this
star this property date less than 2017-06-27more like thismore than 2017-06-27
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of the effect on obtaining authorisations for new drugs of the UK withdrawing from the European Medicines Agency. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 1340 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-07-05more like thismore than 2017-07-05
star this property answer text <p>The extent to which European Medicines Agency procedures will apply in the United Kingdom after we have exited the European Union will be subject to negotiations. Whatever the outcome of negotiations, the Government will ensure that we have a regulatory system that protects the best interests of patients – without regulatory delay in the approval of new medicines - and encourages innovation.</p> more like this
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-07-05T08:23:01.003Zmore like thismore than 2017-07-05T08:23:01.003Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
758746
unstar this property registered interest false more like this
star this property date less than 2017-09-07more like thismore than 2017-09-07
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Tobacco more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will publish details of all communications between his Department and the tobacco industry on the Tobacco Control Plan; and what steps he has taken to encourage tobacco companies to engage with the Government in written, as well as oral, form. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 9323 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-09-14more like thismore than 2017-09-14
star this property answer text <p>The United Kingdom is a signatory to the Framework Convention on Tobacco Control (FCTC). Article 5.3 of the FCTC states that “in setting and implementing their public health policies with respect to tobacco control, Parties shall act to protect these policies from commercial and other vested interests of the tobacco industry in accordance with national law.” The Department has therefore not invited the tobacco industry to contribute to the development of the Tobacco Control Plan. The Government will continue to uphold its obligations under the World Health Organization FCTC.</p> more like this
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-09-14T14:09:17.377Zmore like thismore than 2017-09-14T14:09:17.377Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
800711
unstar this property registered interest false more like this
star this property date less than 2017-12-04more like thismore than 2017-12-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading European Court of Justice: Small Businesses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether he has made an assessment of the effect of leaving the European Court of Justice on small businesses with a specialism in medical devices and who use that Court to resolve disputes. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 117332 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-12-12more like thismore than 2017-12-12
star this property answer text <p>In leaving the European Union, we will bring about an end to the direct jurisdiction of the European Court of Justice in the United Kingdom. The UK Government's future partnership paper sets out the UK’s position on enforcement and reviews examples of mechanisms for resolving disputes in international agreements. It states that as part of the deep and special partnership we seek with the EU, it is in the interests of both the UK and the EU that: the rights and obligations agreed between us can be relied upon and enforced by individuals and businesses; and where disputes arise between the UK and the EU on the application or interpretation of these obligations, those disputes can be resolved efficiently and effectively.</p><p> </p><p>The Government's top priority for life sciences during the negotiations is to protect the safety of patients and ensure the integrity of cross-European public health systems. The Government will seek a mutually beneficial future partnership between the UK and EU that is in the interests of both sides, which builds on the convergence between our regulatory systems and gives business the maximum freedom to trade with and operate within European markets.</p>
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-12-12T17:08:43.163Zmore like thismore than 2017-12-12T17:08:43.163Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
800716
unstar this property registered interest false more like this
star this property date less than 2017-12-04more like thismore than 2017-12-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health what assessment he has made of the potential effect of the UK leaving the Customs Union on the the ability of the NHS to procure medicines and medical devices. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 117337 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-12-12more like thismore than 2017-12-12
star this property answer text <p>The potential implications of the United Kingdom leaving the customs union on the ability of the National Health Service to procure medicines and medical devices are currently being assessed.</p><p> </p><p>It is in the interest of both the UK and European Union to avoid disruption in the timely access of these products; and to ensure that cross-border trade with the EU is as frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.</p> more like this
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-12-12T17:01:50.993Zmore like thismore than 2017-12-12T17:01:50.993Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
808802
unstar this property registered interest false more like this
star this property date less than 2017-12-18more like thismore than 2017-12-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Spondyloarthritis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to improve the collection of data within the NHS at the (a) national and (b) local level on the incidence, prevalence and outcomes of ankylosing spondylitis and psoriatic arthritis. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 119911 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2017-12-22more like thismore than 2017-12-22
star this property answer text <p>Psoriatic arthritis and ankylosing spondylitis are part of group of musculoskeletal conditions referred to collectively as spondyloarthritis. This term also refers to conditions including: reactive arthritis; enteropathic arthritis; and undifferentiated spondyloarthritis. The National Institute for Health and Care Excellence advises that spondyloarthritis has a reported prevalence in Western Europe of between 0.8% in 1.7%.</p><p> </p><p>Improving Lives - the Work, Health and Disability Green Paper, published on 31 October 2016, set out the Government’s commitment to work with NHS England to identify opportunities for regular collection of data about incidence, prevalence, clinical activity and outcomes of musculoskeletal conditions and services in England. The Government’s Mandate to NHS England reiterated this commitment. On 30 November 2017 the Government published Improving Lives - The Future of Work, Health and Disability in response to the Green Paper. In building on the commitment in the Green Paper to identify opportunities for routine data collection about musculoskeletal incidence, prevalence, clinical activity, and outcomes, the report set out that a data advisory group, led by Arthritis Research UK, has been examining the issue. On 1 December 2017 the advisory group presented its recommendations to NHS England, which is currently considering the appropriate next steps. Improving Lives - The Future of Work, Health and Disability can be found at the following link:</p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability" target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p>
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-12-22T12:59:01.463Zmore like thismore than 2017-12-22T12:59:01.463Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
810508
unstar this property registered interest false more like this
star this property date less than 2017-12-21more like thismore than 2017-12-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Chronic Fatigue Syndrome more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking as a result of the latest evidence on the diagnosis and treatment of Chronic Fatigue Syndrome. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 120854 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-01-12more like thismore than 2018-01-12
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent expert body responsible for developing robust, evidence based guidance for the National Health Service to support it in designing services that are in line with the best available evidence.</p><p> </p><p>The NICE guideline Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children sets outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and assists commissioners in planning services for local populations. The full guideline can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53" target="_blank">www.nice.org.uk/guidance/cg53</a></p><p>NICE routintely reviews its guidance to ensure it reflects the lastest available evidence. On 20 September 2017, NICE announced its decision to undertake a full update of the CFS/ME guidance. More information on this decision can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941" target="_blank">www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941</a></p>
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-12T11:23:31.657Zmore like thismore than 2018-01-12T11:23:31.657Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
819795
unstar this property registered interest false more like this
star this property date less than 2018-01-10more like thismore than 2018-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Spondyloarthritis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what mechanisms have been put in place to identify accurately the number of individuals diagnosed with ankylosing spondylitis and psoriatic arthritis within the NHS in England. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 121867 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-01-18more like thismore than 2018-01-18
star this property answer text <p>Improving Lives - The Work, Health and Disability Green Paper, published on 31 October 2016, sets out the Government’s commitment to work with NHS England to identify opportunities for regular collection of data about incidence, prevalence, clinical activity and outcomes of musculoskeletal (MSK) conditions and services in England. The Government’s Mandate to NHS England reiterated this commitment.</p><p> </p><p>On 30 November 2017, the Government published Improving Lives - The Future of Work, Health and Disability in response to the Green Paper. This builds on the commitment to identify opportunities for routine data collection about MSK incidence, prevalence, clinical activity, and outcomes. The report outlined that a data advisory group, led by Arthritis Research UK, has been examining the issue. On 1 December 2017, the advisory group presented its recommendations to NHS England, which is currently considering the appropriate next steps.</p><p> </p><p>Improving Lives - The Future of Work, Health and Disability can be found at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability" target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p>
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-18T14:07:08.423Zmore like thismore than 2018-01-18T14:07:08.423Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
834613
unstar this property registered interest false more like this
star this property date less than 2018-02-01more like thismore than 2018-02-01
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Ankylosing Spondylitis and Arthritis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 December to Question 119911 on Ankylosing Spondylitis and Arthritis , when NHS England plans to announce its next steps in relation to the recommendations it was presented with on 1 December 2017 by the data advisory group, led by Arthritis Research UK; and whether there will be a wider consultation on the opportunities for improved routine data collection on musculoskeletal incidence, prevalence, clinical activity, and outcomes. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 126061 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-02-08more like thismore than 2018-02-08
star this property answer text <p>NHS England’s work to consider the recommendations of the data advisory group is ongoing. Information on the next steps will be available in due course.</p> more like this
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-08T14:48:37.423Zmore like thismore than 2018-02-08T14:48:37.423Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
845522
unstar this property registered interest false more like this
star this property date less than 2018-02-20more like thismore than 2018-02-20
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading WHO Framework Convention on Tobacco Control more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when the Government plans to (a) ratify the WHO Framework Convention on Tobacco Control and (b) deposit the instrument of ratification at the UN in New York. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 128494 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-02-23more like thismore than 2018-02-23
star this property answer text <p>The United Kingdom ratified the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) on the 16 December 2004. The WHO FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products on 12 November 2012. The Government is fully committed to the Protocol. It is current UK Government policy that international treaties will not be ratified until all the legislation required for implementation has been passed by Parliament. A Command Paper setting out the UK’s plans to ratify the World Health Organization Protocol to Eliminate Illicit Trade in Tobacco Products now needs to be laid before Parliament. Preparations, led by HM Revenue and Customs, are underway and they expect to proceed shortly.</p> more like this
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-23T12:17:57.117Zmore like thismore than 2018-02-23T12:17:57.117Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this
846084
unstar this property registered interest false more like this
star this property date less than 2018-02-21more like thismore than 2018-02-21
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rare Diseases more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to his Department's policy paper, UK strategy for rare diseases: implementation plan for England, published on 29 January 2018, what steps he is taking to increase cross-border collaboration (a) within the UK and (b) between the UK and the EU in developing approaches to treatment and management of rare diseases. more like this
star this property tabling member constituency Linlithgow and East Falkirk remove filter
star this property tabling member printed
Martyn Day more like this
star this property uin 128792 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-01more like thismore than 2018-03-01
star this property answer text <p>The activities described in the Department’s ‘UK Strategy for Rare Diseases: implementation plan for England’ are those that are shared between the Department and a number of partner organisations in implementing the UK Strategy for Rare Diseases. This implementation plan applies to England only.</p><p> </p><p>The UK Rare Disease Policy Board, which has representation of all four United Kingdom nations, oversees the implementation of the UK Strategy for Rare Diseases across the UK. The UK Rare Disease Policy Board publishes on a biennial basis an update on the implementation activities across the whole of the UK. The next report was published on 28 February 2018 and will highlight, in greater detail, initiatives and achievements across the four nations over the past two years, as well as look at UK-wide developments and challenges in the rare diseases landscape that will be important in the forward look to 2020.</p><p> </p><p>The UK is involved in European Reference Networks, virtual centres of knowledge, skills and expertise in the field of rare diseases and complex conditions, which provide a platform to create partnerships between healthcare providers. The UK participates in 23 out of the 24 networks (involving 113 separate UK groups) and leads six networks.</p>
unstar this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-01T15:08:15.51Zmore like thismore than 2018-03-01T15:08:15.51Z
star this property answering member
4067
unstar this property label Biography information for Steve Brine more like this
star this property tabling member
4488
star this property label Biography information for Martyn Day more like this